Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01313390
What this trial is testing

Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University College, London 4
Early research (Phase 1)Study completedNCT02277197
What this trial is testing

Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Carcinoma, Squamous Cell of Head and NeckSquamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma, Head And Neck
James J Lee 14
Not applicableLooking for participantsNCT06662058
What this trial is testing

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Cutaneous Squamous Cell Carcinoma of the Head and NeckHead and Neck Carcinoma of Unknown Primary+30 more
Emory University 118
Early research (Phase 1)Study completedNCT03524326
What this trial is testing

Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaCutaneous Squamous Cell CarcinomaHead and Neck Cancer+1 more
Memorial Sloan Kettering Cancer Center 24
Early research (Phase 1)Study completedNCT00470496
What this trial is testing

Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity+52 more
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06714266
What this trial is testing

Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Shandong Cancer Hospital and Institute 30
Testing effectiveness (Phase 2)Study completedNCT00448552
What this trial is testing

Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Miami 30
Large-scale testing (Phase 3)Study completedNCT07435324
What this trial is testing

A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
R-Pharm 161
Testing effectiveness (Phase 2)Study completedNCT00055770
What this trial is testing

Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+19 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)WithdrawnNCT01427205
What this trial is testing

Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00093041
What this trial is testing

Zalutumumab in Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Genmab 28
Not applicableStudy completedNCT01619618
What this trial is testing

Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group 183
Large-scale testing (Phase 3)Active Not RecruitingNCT05063552
What this trial is testing

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+20 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03049618
What this trial is testing

Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475

Who this might be right for
ALK Gene MutationBRAF Gene MutationEGFR Gene Mutation+9 more
University of Southern California 42
Large-scale testing (Phase 3)Study completedNCT00122460
What this trial is testing

Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)

Who this might be right for
Head and Neck Cancer
Merck KGaA, Darmstadt, Germany 442
Testing effectiveness (Phase 2)Study completedNCT00387335
What this trial is testing

Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Squamous Cell Carcinoma of the Hypopharynx+11 more
National Cancer Institute (NCI) 22
Not applicableStudy completedNCT00896896
What this trial is testing

Immunoreactivity to Cetuximab in Cancer Patients

Who this might be right for
Colorectal CancerHead and Neck Cancer
Vanderbilt-Ingram Cancer Center 538
Testing effectiveness (Phase 2)Study completedNCT01087970
What this trial is testing

Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Eli Lilly and Company 69
Testing effectiveness (Phase 2)Ended earlyNCT02633800
What this trial is testing

Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )

Who this might be right for
Head and Neck Neoplasms
Daiichi Sankyo 87
Large-scale testing (Phase 3)Study completedNCT02105636
What this trial is testing

Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Bristol-Myers Squibb 361
Next Page
430